Patriot Financial Group Insurance Agency’s Aimmune Therapeutics AIMT Stock Holding History

Patriot Financial Group Insurance Agency’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-140	Closed	-$5K	–	2063
2020 Q3	$5K	Buy	+140	New	+$2.98K	﹤0.01%	1261

Patriot Financial Group Insurance Agency's AIMT Position: Q4 2020 in Review

Patriot Financial Group Insurance Agency sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 140 shares — an estimated $5K sold.

Patriot Financial Group Insurance Agency first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $5K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Patriot Financial Group Insurance Agency reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Patriot Financial Group Insurance Agency sold 140 Aimmune Therapeutics shares in Q4 2020, an estimated $5K.
Patriot Financial Group Insurance Agency first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
Patriot Financial Group Insurance Agency's Aimmune Therapeutics position peaked at $5K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q4 2020, filed 15 Jan 2021.